56S0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 18.5 EUR 0.54% Market Closed

Market Cap: €18B

	Sartorius Stedim Biotech SA F:56S0	FR
	JD.Com Inc HKEX:9618	CN
	Dave & Buster's Entertainment Inc NASDAQ:PLAY	US
E	Emmi AG XMUN:FV6	CH
	Lynas Rare Earths Ltd XMUN:LYI	AU
C	CNOOC Ltd XBER:NC2B	CN
	Guanajuato Silver Company Ltd OTC:GSVRF	CA
A	Avista Corp DUS:AV6	US
	Money Forward Inc OTC:MNYFF	JP
B	Beigene Ltd XMUN:49B	KY
	Total Energy Services Inc F:5O7	CA
	DW8 Ltd ASX:DW8	AU
H	Huron Consulting Group Inc F:HUR	US

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

52% > 45%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

23% > 18%

Low Net Margin

Low 3Y Average Net Margin

10%

Declining Net Margin

20% > 9%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.